Visión generalGráficoNoticiasTraderScreen

Boston Therapeutics/  US63008H1023  /

Nasdaq Other OTC
-  - Diferencia - Volumen Bid- Ask- Máximo del día Price Change Band
-USD - -
Volumen de negocios: -		 -Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - - -
GlobeNewswire 12/11/2021 IR-Med to Become Fully Reporting SEC Company
GlobeNewswire 22/08/2019 Boston Therapeutics Ph 2 Study Achieves Full Enrollment
GlobeNewswire 14/02/2019 Boston Therapeutics Announces Official Sales and Marketing Launch of Sugardown® in Asia
GlobeNewswire 13/12/2018 Boston Therapeutics Announces Marketing of Sugardown® in Asia
GlobeNewswire 07/12/2018 Boston Therapeutics Announces Initiation of Sales of Sugardown® in Asia
GlobeNewswire 03/10/2018 Boston Therapeutics and Prevail InfoWorks Announce Strategic Clinical Partnership
GlobeNewswire 24/09/2018 Boston Therapeutics Initiates New Exploratory and Adaptive Multicenter Clinical Study of BTI320 On T...
GlobeNewswire 24/08/2018 Boston Therapeutics Phase IIa Study Results Accepted for Publication
GlobeNewswire 09/08/2018 Boston Therapeutics to launch social commerce channel for Sugardown® in China
GlobeNewswire 27/06/2018 Boston Therapeutics Introduces Sugardown® to the US under kathy Ireland® Health & Wellness
GlobeNewswire 22/05/2018 Boston Therapeutics Initiates New Clinical Study of BTI-320
GlobeNewswire 10/05/2018 Boston Therapeutics Phase I Study Results Accepted for Publication
GlobeNewswire 27/04/2018 Boston Therapeutics Corporate Call Transcript Posted
GlobeNewswire 16/04/2018 Boston Therapeutics to Hold Business Update Conference Call Wednesday, April 18, 2018 at 5:00 p.m. E...
GlobeNewswire 12/04/2018 Boston Therapeutics Announces Letter of Intent to Acquire Pennsylvania-based Medical Technology Asso...
GlobeNewswire 06/04/2018 Boston Therapeutics Awarded Key European Patent
GlobeNewswire 29/03/2018 Boston Therapeutics Engages Medical and FDA Experts: Launching New Strategic Initiatives
GlobeNewswire 27/03/2018 Boston Therapeutics Creates New Scientific Advisory Board
GlobeNewswire 08/03/2018 Boston Therapeutics Joins the Biotechnology Innovation Organization (BIO)
GlobeNewswire 20/02/2018 Boston Therapeutics Announces New COO, Loraine V. Upham
GlobeNewswire 13/02/2018 Boston Therapeutics Announces Strategic Acquisition of CureDM
GlobeNewswire 16/01/2018 Boston Therapeutics, Inc. Introductory Social Media Launch (www.bostonti.com)
GlobeNewswire 14/12/2017 Boston Therapeutics, Inc. Expands Partnership with APC to Distribute in Korea
GlobeNewswire 06/12/2017 Boston Therapeutics, Inc. Announces New Dosing Regimen for BTI320
GlobeNewswire 17/11/2017 Boston Therapeutics Shareholder Update